Novo Nordisk Foundation
Novo Nordisk Foundation Commits Over $850M to Danish Life Science Incubator BII Over Next Decade
Novo Nordisk Foundation; BII; life science incubator; $850M; biotech startups; Denmark
Novo Nordisk CEO and Board Leadership Step Down Amid Market Pressures; New Board to Prioritize Faster Decision-Making
Novo Nordisk; CEO resignation; Lars Fruergaard Jørgensen; board leadership change; Novo Nordisk Foundation; share price decline; strategic decision-making; competition; Lars Rebien Sørensen; executive transition